heart medications

12345678910111213141516171819202122
Across
  1. 5. 1-2 of these should be the maximum amount of time spent on pushing in adenosine
  2. 6. this describes how often you will assess perfusion while on epinephrine
  3. 8. Agents that improve myocardial contractility and enhance stroke volume
  4. 9. is administered to keep the PDA open for ductal dependent congenital heart defects
  5. 10. this is improved when dopamine is being administered
  6. 14. describes the proper method to administer dopamine
  7. 15. this causes vasodilation, improves contractility of the heart, and decreases PVR and SVR
  8. 16. describes the systemic vascular resistance while on dopamine
  9. 19. this demand is increased by the myocardium while on epinephrine
  10. 21. describes what happens to the tissue around a PIV that is infiltrated while administering dobutamine
  11. 22. agents that increase systemic vascular resistance thus increasing blood pressure
Down
  1. 1. describes the rate at which to administer calcium so as not to cause hypotension
  2. 2. is the side effect of most concern while caring for a patient on prostaglandin E
  3. 3. describes what happens to the peripheral vasculature while on epinephrine
  4. 4. has more of an effect on cardiac output than dopamine with less effect on blood pressure
  5. 7. is a cardiac stimulant that increases heart rate and the strength of cardiac contractions
  6. 11. is an inotrope that is the first line drug for low blood pressure in the NICU
  7. 12. a sign of this drug is reaching toxic levels is bradycardia
  8. 13. describes how frequently you would record vital signs while on inotropes
  9. 17. is the drug used to treat SVT
  10. 18. describes the low dose of dopamine at 1-3 mcg/kg/min
  11. 20. is the device used to help administer adenosine appropriately